TFEC inhibitors belong to a specialized category of chemical compounds that have garnered attention in the field of molecular biology and transcriptional regulation. TFEC, or Transcription Factor EC, is a transcription factor that plays a significant role in regulating gene expression in various cellular contexts. TFEC is a member of the MiT-TFE family of transcription factors, which includes other family members like MITF, TFE3, and TFEB. These transcription factors are involved in controlling a wide range of cellular processes, such as lysosomal biogenesis, autophagy, and response to stress. TFEC itself is known to be associated with the regulation of lysosomal genes and autophagy-related genes, contributing to cellular homeostasis and the maintenance of lysosomal function. TFEC inhibitors are chemical compounds designed to interact with TFEC, potentially modulating its transcriptional activity and influencing the expression of genes involved in lysosomal and autophagic processes.
The mechanism of action of TFEC inhibitors typically involves their binding to specific regions or domains within the TFEC protein, often altering its ability to interact with DNA and regulate target genes. This interaction can lead to changes in TFEC's ability to activate or repress gene expression, affecting the transcription of genes associated with lysosomal biogenesis and autophagy. Consequently, TFEC inhibitors may have implications for various cellular processes, including lysosomal function, cellular waste disposal, and cellular responses to stress and nutrient availability, offering insights into the molecular mechanisms that govern these critical cellular pathways. The study of TFEC inhibitors is instrumental in advancing our understanding of gene regulation and cellular homeostasis, providing valuable tools for investigating the roles of TFEC in various cellular contexts and its impact on cellular processes related to lysosomal function and autophagy.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Acts on transcription factors and inhibits RNA polymerase II, potentially reducing TFEC expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to G-C-rich DNA sequences, possibly preventing the binding of transcription factors to promoters, including that of TFEC. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Intercalates into DNA and inhibits RNA polymerase, potentially downregulating TFEC transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could alter the methylation status of TFEC gene promoter, affecting its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, which could alter chromatin structure and reduce TFEC expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, could indirectly inhibit TFEC expression by altering chromatin accessibility. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, might reduce the degradation of proteins that regulate TFEC transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Like 5-Azacytidine, can inhibit DNA methylation, potentially affecting TFEC expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits translation initiation and might suppress the expression of TFEC at the translational level. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Topoisomerase I inhibitor, may cause DNA damage and consequently reduce transcription of various genes including TFEC. | ||||||